Invention Grant
- Patent Title: Antibodies specific for CD47, PD-L1, and uses thereof
-
Application No.: US17120935Application Date: 2020-12-14
-
Publication No.: US11702474B2Publication Date: 2023-07-18
- Inventor: Javier Fernando Chaparro Riggers , Shih-Hsun Chen , Sheng Ding , Pawel Kamil Dominik , Shahram Salek-Ardakani , Jessica Lynn Stanfield , Thomas John Van Blarcom
- Applicant: Pfizer Inc.
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Agent Stephen E. Moyer
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61P35/00 ; A61K39/00
Abstract:
Antibodies that specifically bind to CD47 and antibodies that specifically bind to PD-L1 are provided, as well as CD47/PD-L1 bispecific antibodies. Also provided are uses of these antibodies, and related compositions and methods.
Public/Granted literature
- US20210179716A1 Antibodies Specific for CD47, PD-L1, and Uses Thereof Public/Granted day:2021-06-17
Information query
